References
- Schepelmann K, Winter Y, Spottke A, Claus D, Grothe C, Schröder R, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257:15–23.
- Jennum P, Ibsen R, Pedersen S, Kellberg J.Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. J Neurol. 2013;260: 785–93.
- van der Steen I, van den Berg JP, Buskens E, Lindeman E, van den Berg LH. The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler. 2009; 10:27–34.
- Corr B, Frost E, Traynor B, Hardiman O.Service provision for patients with ALS/MND: a cost-effective multidisciplinary approach. J Neurosurg Sci. 1998;160(Suppl 1): S135–41.
- Department of Health and Children. Case-mix measurement in Irish hospitals: a broad outline of the main features. Dublin: Department of Health and Children; 2003.
- Carpenter J, Bithell J.Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19:1141–64.
- Tilson L, Sharp L, Usher C, Walsh C, Whyte S, O’Ceilleachair A, et al. Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ. 2012;13:511–24.
- Economic and Social Research Institute and the Royal College of Surgeons in Ireland (2010). Cost of stroke in Ireland: estimating the annual economic cost of stroke and transient ischaemic attack (TIA) in Ireland. Irish Heart Foundation, Ireland.
- Connolly S, Gillespie P, O’Shea E, Cahill S, Pierce M. Estimating the economic and social costs of dementia in Ireland. Dementia: the International Journal of Social Research and Practice. 2014;13:5–22.